Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results

OBJECTIVES: Adjuvant chemotherapy decision in patients with hormone receptor positive, HER2 negative breast cancer (BC) is challenging. Ki-67 is widely used for adjuvant therapy decision in BC. The multigene assay EndoPredict (EP) has shown to provide valid and additional information about the risk...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast
Main Authors: Noske, Aurelia, Anders, Sophie-Isabelle, Ettl, Johannes, Hapfelmeier, Alexander, Steiger, Katja, Specht, Katja, Weichert, Wilko, Kiechle, Marion, Klein, Evelyn
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7375593/
https://ncbi.nlm.nih.gov/pubmed/31786414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2019.11.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados